Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 125,132 | 94,206 | 83,932 | 80,141 | 57,194 |
| Operating Income | -125,132 | -94,206 | -83,932 | -80,141 | -57,194 |
| Interest Expense | 1,823 | 1,905 | 1,960 | 1,874 | 1,792 |
| Other Income | 5,923 | 5,015 | 5,599 | 5,484 | 7,292 |
| Pre-tax Income | -121,032 | -91,096 | -80,293 | -76,531 | -51,694 |
| Net Income Continuous | -121,032 | -91,095 | -80,293 | -76,531 | -51,694 |
| Net Income | $-121,032 | $-91,095 | $-80,293 | $-76,531 | $-51,694 |
| EPS Basic Total Ops | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 |
| EPS Basic Continuous Ops | -1.69 | -1.40 | -1.26 | -1.20 | -0.81 |
| EPS Diluted Total Ops | -1.69 | -1.39 | -1.26 | -1.20 | -0.81 |
| EPS Diluted Continuous Ops | -1.69 | -1.40 | -1.26 | -1.20 | -0.81 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.39 | -1.26 | -1.20 | -0.81 |
| EBITDA(a) | $-125,196 | $-94,543 | $-84,411 | $-81,756 | $-59,419 |